Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Annals of the Academy of Medicine, Singapore
|
May 6, 2016
Viva-Asia Blood and Marrow Transplantation Groups - A Survey of Consortium Activity over a 12-year Period (2000 to 2011)
Ah Moy Tan, Christina Ha, Chun Fu Li, et al.
BMC Gastroenterology
|
May 13, 2017
Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease
Diana Hoang-Ngoc Tran, Jiani Wang, Christina Ha, et al.
Inflammatory Bowel Diseases
|
August 22, 2020
Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States
Benjamin L Cohen, Zane R Gallinger, Christina Ha, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 7, 2022
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study
Siddharth Singh, Jihoon Kim, Jiyu Luo, et al.
JCI Insight
|
November 23, 2021
p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes
Vitor F Martins, Samuel A LaBarge, Alexandra Stanley, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 17, 2020
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium
Marc Fenster, Quazim A Alayo, Aava Khatiwada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 1, 2022
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study
Nghia H Nguyen, Jiyu Luo, Paulina Paul, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 7, 2020
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis
Parakkal Deepak, Quazim A Alayo, Aava Khatiwada, et al.
The American Journal of Gastroenterology
|
August 16, 2022
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study
Phillip Gu, Jiyu Luo, Jihoon Kim, et al.
Alimentary Pharmacology & Therapeutics
|
March 12, 2022
A United States expert consensus to standardise definitions, follow-up, and treatment targets for extra-intestinal manifestations in inflammatory bowel disease
Katherine Falloon, Benjamin Cohen, Ashwin N Ananthakrishnan, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Annals of the Academy of Medicine, Singapore
|
May 6, 2016
Viva-Asia Blood and Marrow Transplantation Groups - A Survey of Consortium Activity over a 12-year Period (2000 to 2011)
Ah Moy Tan, Christina Ha, Chun Fu Li, et al.
BMC Gastroenterology
|
May 13, 2017
Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease
Diana Hoang-Ngoc Tran, Jiani Wang, Christina Ha, et al.
Inflammatory Bowel Diseases
|
August 22, 2020
Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States
Benjamin L Cohen, Zane R Gallinger, Christina Ha, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 7, 2022
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study
Siddharth Singh, Jihoon Kim, Jiyu Luo, et al.
JCI Insight
|
November 23, 2021
p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes
Vitor F Martins, Samuel A LaBarge, Alexandra Stanley, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 17, 2020
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium
Marc Fenster, Quazim A Alayo, Aava Khatiwada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 1, 2022
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study
Nghia H Nguyen, Jiyu Luo, Paulina Paul, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 7, 2020
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis
Parakkal Deepak, Quazim A Alayo, Aava Khatiwada, et al.
The American Journal of Gastroenterology
|
August 16, 2022
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study
Phillip Gu, Jiyu Luo, Jihoon Kim, et al.
Alimentary Pharmacology & Therapeutics
|
March 12, 2022
A United States expert consensus to standardise definitions, follow-up, and treatment targets for extra-intestinal manifestations in inflammatory bowel disease
Katherine Falloon, Benjamin Cohen, Ashwin N Ananthakrishnan, et al.
Page
of 6